Rare diseases
Investigational molecules
Locations
Back to Belgium1 305 clinical trials in Charleroi, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on VE303 for Preventing Recurrent C. difficile Infection in Patients
BelgiumStudy of Elenestinib for Patients with Indolent Systemic Mastocytosis
BelgiumStudy of OSE-279 and OSE2101 Drug Combination for Patients with Advanced Solid Tumors, Lymphomas, or Metastatic Non-Small Cell Lung Cancer
BelgiumStudy of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine
BelgiumStudy on STC-1010 and Drug Combination for Patients with Advanced or Metastatic Colorectal Cancer
BelgiumStudy on Doxapram for Treating Apnea in Preterm Newborns
BelgiumStudy on Treating Chronic Lymphocytic Leukemia with Venetoclax and Acalabrutinib for Patients Whose Disease Has Returned After Initial Treatment
BelgiumStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination
BelgiumStudy on Pembrolizumab and Radiotherapy for Patients with Limited Spread of Head and Neck Cancer
BelgiumStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
BelgiumStudy of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
BelgiumBelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in breast cancer, lung cancer, and head and neck cancers. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple trials investigating personalized medicine approaches and biomarker-driven treatments.
Research examining treatments for coronary artery disease and post-cardiac arrest care. Trials focus on innovative stent technologies and antiplatelet therapy optimization.
Emphasis on improving patient outcomes through targeted interventional approaches.
Clinical investigations targeting inflammatory skin conditions and immune-mediated disorders. Studies evaluate novel treatments for psoriasis and other dermatological conditions.
Focus on developing targeted therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
